Management of kidney cancer: canadian kidney cancer forum consensus update 2011.
作者信息
Jewett Mas, Finelli A, Kollmannsberger C, Wood L, Legere L, Basiuk J, Canil C, Heng D, Reaume N, Tanguay S, Atkins M, Bjarnason G, Dancey J, Evans M, Fleshner N, Haider M, Kapoor A, Uzzo R, Maskens D, Soulieres D, Yousef G, Basappa N, Bendali N, Black P, Blais N, Cagiannos I, Care M, Chow R, Chung H, Czaykowski P, Derosa D, Durrant K, Ellard S, Farquharson G, Filion-Brulotte C, Gingerich J, Godbout L, Grant R, Hamilton W, Kassouf W, Kurban G, Lane K, Lattouf Jb, Lau D, Leveridge M, McCarthy J, Moore R, North S, O'brien P, Pituskin E, Racine P, Rendon R, So A, Sridhar S, Stubbs K, Su Z, Taylor L, Udall T, Venner P, Vogel W, Yap S, Yau P, Cooper M, Giroux N, Miron D, Mosher D, Ross K, Willacy J
出版信息
Can Urol Assoc J. 2012 Feb;6(1):16-22. doi: 10.5489/cuaj.11273.
Abstract
摘要
相似文献
1
Management of kidney cancer: canadian kidney cancer forum consensus update 2011.肾癌的管理：2011年加拿大肾癌论坛共识更新
Can Urol Assoc J. 2012 Feb;6(1):16-22. doi: 10.5489/cuaj.11273.
2
Management of advanced kidney cancer: Canadian Kidney Cancer Forum 2013 Consensus Update: Canadian Kidney Cancer Forum 2013.晚期肾癌的管理：2013年加拿大肾癌论坛共识更新：2013年加拿大肾癌论坛
Can Urol Assoc J. 2013 Jul-Aug;7(7-8):238-43. doi: 10.5489/cuaj.536.
3
Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update.晚期肾癌的管理：加拿大肾癌论坛共识更新
Can Urol Assoc J. 2015 May-Jun;9(5-6):164-70. doi: 10.5489/cuaj.2894.
4
Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.晚期肾癌的管理：2017年加拿大肾癌论坛（CKCF）共识更新
Can Urol Assoc J. 2017 Oct;11(10):310-320. doi: 10.5489/cuaj.4769.
5
Management of kidney cancer: Canadian Kidney Cancer Forum Consensus Statement.肾癌的管理：加拿大肾癌论坛共识声明
Can Urol Assoc J. 2008 Jun;2(3):175-82.
6
Surgical management of renal cell carcinoma: Canadian Kidney Cancer Forum Consensus.肾细胞癌的外科治疗：加拿大肾癌论坛共识
Can Urol Assoc J. 2014 May;8(5-6):E398-412. doi: 10.5489/cuaj.1894.
7
Controversial issues in the management of patients with advanced prostate cancer: Results from a Canadian consensus forum.晚期前列腺癌患者管理中的争议问题：加拿大共识论坛的结果
Can Urol Assoc J. 2020 Apr;14(4):E137-E149. doi: 10.5489/cuaj.6082. Epub 2019 Nov 5.
8
Canadian Forum on Combined Organ Transplantation.加拿大联合器官移植论坛。
Transplantation. 2016 Jun;100(6):1339-48. doi: 10.1097/TP.0000000000000963.
9
Report of the 2003 pan-Canadian forum on cervical cancer prevention and control.2003年加拿大全国子宫颈癌预防与控制论坛报告。
J Obstet Gynaecol Can. 2004 Nov;26(11):1004-28. doi: 10.1016/s1701-2163(16)30423-6.
10
Canadian Cardiovascular Society Clinical Practice Update on the Assessment and Management of Syncope.加拿大心血管学会晕厥评估和管理的临床实践更新。
Can J Cardiol. 2020 Aug;36(8):1167-1177. doi: 10.1016/j.cjca.2019.12.023. Epub 2020 Jul 2.
引用本文的文献
1
Role of F-18 FDG PET/CT in the follow-up of asymptomatic renal cell carcinoma patients for postoperative surveillance: based on conditional survival analysis.基于条件生存分析，F-18 FDG PET/CT 在无症状肾细胞癌患者术后随访中的作用：用于术后监测。
J Cancer Res Clin Oncol. 2022 Jan;148(1):215-224. doi: 10.1007/s00432-021-03688-2. Epub 2021 Jun 9.
2
Management of advanced kidney cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2021.晚期肾癌的管理：加拿大肾癌研究网络（KCRNC）2021年共识更新
Can Urol Assoc J. 2021 Apr;15(4):84-97. doi: 10.5489/cuaj.7245.
3
Management of Advanced Kidney Cancer: Kidney Cancer Research Network of Canada (KCRNC) consensus update 2019.晚期肾癌的管理：加拿大肾癌研究网络（KCRNC）2019年共识更新
Can Urol Assoc J. 2019 Oct;13(10):343-354. doi: 10.5489/cuaj.6256.
4
Cystic Renal Cell Carcinoma: A Report on Outcomes of Surgery and Active Surveillance in Patients Retrospectively Identified on Pretreatment Imaging.囊性肾细胞癌：术前影像学检查回顾性识别的患者手术和主动监测结果报告。
J Urol. 2018 Aug;200(2):275-282. doi: 10.1016/j.juro.2018.02.3087. Epub 2018 Mar 1.
5
Management of advanced kidney cancer: Canadian Kidney Cancer Forum (CKCF) consensus update 2017.晚期肾癌的管理：2017年加拿大肾癌论坛（CKCF）共识更新
Can Urol Assoc J. 2017 Oct;11(10):310-320. doi: 10.5489/cuaj.4769.
6
Follow-up imaging after nephrectomy for cancer in Canada: urologists' compliance with guidelines. An observational study.加拿大肾癌肾切除术后的随访影像学检查：泌尿外科医生对指南的遵循情况。一项观察性研究。
CMAJ Open. 2017 Dec 11;5(4):E834-E841. doi: 10.9778/cmajo.20170005.
7
Management of advanced kidney cancer: Canadian Kidney Cancer Forum consensus update.晚期肾癌的管理：加拿大肾癌论坛共识更新
Can Urol Assoc J. 2015 May-Jun;9(5-6):164-70. doi: 10.5489/cuaj.2894.
8
Canadian guidelines for SRMs: How Canadian are they?
Can Urol Assoc J. 2015 May-Jun;9(5-6):163-213. doi: 10.5489/cuaj.3040.
9
Canadian guidelines for the management of small renal masses (SRM).加拿大小肾肿块（SRM）管理指南。
Can Urol Assoc J. 2015 May-Jun;9(5-6):160-3. doi: 10.5489/cuaj.2969.
10
Landmarks in the diagnosis and treatment of renal cell carcinoma.肾细胞癌的诊断和治疗要点。
Nat Rev Urol. 2014 Sep;11(9):517-25. doi: 10.1038/nrurol.2014.194. Epub 2014 Aug 12.
本文引用的文献
1
Outcomes of small renal mass needle core biopsy, nondiagnostic percutaneous biopsy, and the role of repeat biopsy.小肾肿瘤针芯活检、非诊断性经皮活检的结果及重复活检的作用。
Eur Urol. 2011 Sep;60(3):578-84. doi: 10.1016/j.eururo.2011.06.021. Epub 2011 Jun 24.
2
ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease.2010 年国际肾脏肿瘤研讨会（ICUD-EAU）：转移性疾病的治疗。
Eur Urol. 2011 Oct;60(4):684-90. doi: 10.1016/j.eururo.2011.06.017. Epub 2011 Jun 24.
3
Active surveillance of small renal masses: progression patterns of early stage kidney cancer.小肾肿瘤的主动监测：早期肾癌的进展模式。
Eur Urol. 2011 Jul;60(1):39-44. doi: 10.1016/j.eururo.2011.03.030. Epub 2011 Apr 1.
4
Growth kinetics of renal masses: analysis of a prospective cohort of patients undergoing active surveillance.肾脏肿块的生长动力学：行主动监测的前瞻性队列患者分析。
Eur Urol. 2011 May;59(5):863-7. doi: 10.1016/j.eururo.2011.02.023. Epub 2011 Feb 22.
5
Chronic kidney disease before and after partial nephrectomy.部分肾切除术前、后慢性肾脏病。
J Urol. 2011 Jan;185(1):43-8. doi: 10.1016/j.juro.2010.09.019. Epub 2010 Nov 12.
6
The impact of cytoreductive nephrectomy on survival of patients with metastatic renal cell carcinoma receiving vascular endothelial growth factor targeted therapy.细胞减灭性肾切除术对接受血管内皮生长因子靶向治疗的转移性肾细胞癌患者生存的影响。
J Urol. 2011 Jan;185(1):60-6. doi: 10.1016/j.juro.2010.09.012. Epub 2010 Nov 12.
7
Impact of nephron sparing on kidney function and non-oncologic mortality.保肾对肾功能和非肿瘤死亡率的影响。
Urol Oncol. 2010 Sep-Oct;28(5):568-74. doi: 10.1016/j.urolonc.2010.03.018.
8
Renal mass biopsy to guide treatment decisions for small incidental renal tumors: a cost-effectiveness analysis.肾肿瘤活检指导小偶发肾肿瘤治疗决策：成本效益分析。
Radiology. 2010 Sep;256(3):836-46. doi: 10.1148/radiol.10092013.
9
Contemporary management of renal tumors with venous tumor thrombus.当代肾肿瘤伴静脉瘤栓的治疗方法。
J Urol. 2010 Sep;184(3):833-41; quiz 1235. doi: 10.1016/j.juro.2010.04.071.
10
Phase 3 trial of everolimus for metastatic renal cell carcinoma : final results and analysis of prognostic factors.依维莫司治疗转移性肾细胞癌的 3 期临床试验：最终结果和预后因素分析。
Cancer. 2010 Sep 15;116(18):4256-65. doi: 10.1002/cncr.25219.
Zotero 插件